Teleflex Incorporated (NYSE:TFX) Shares Acquired by Rhumbline Advisers

Rhumbline Advisers increased its stake in shares of Teleflex Incorporated (NYSE:TFX - Free Report) by 16.3% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 116,322 shares of the medical technology company's stock after acquiring an additional 16,308 shares during the quarter. Rhumbline Advisers owned about 0.26% of Teleflex worth $16,074,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Vontobel Holding Ltd. grew its position in Teleflex by 21.9% during the 4th quarter. Vontobel Holding Ltd. now owns 1,393 shares of the medical technology company's stock worth $248,000 after purchasing an additional 250 shares during the last quarter. Sumitomo Mitsui Trust Group Inc. boosted its holdings in Teleflex by 5.2% during the fourth quarter. Sumitomo Mitsui Trust Group Inc. now owns 108,231 shares of the medical technology company's stock worth $19,263,000 after buying an additional 5,322 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. raised its position in Teleflex by 35.1% during the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 5,875 shares of the medical technology company's stock worth $1,053,000 after acquiring an additional 1,527 shares during the last quarter. Lecap Asset Management Ltd. acquired a new position in Teleflex during the fourth quarter worth about $729,000. Finally, Asset Management One Co. Ltd. raised its position in Teleflex by 15.6% during the fourth quarter. Asset Management One Co. Ltd. now owns 19,233 shares of the medical technology company's stock worth $3,453,000 after acquiring an additional 2,589 shares during the last quarter. 95.62% of the stock is currently owned by institutional investors and hedge funds.

Teleflex Stock Up 0.2%

Shares of NYSE:TFX opened at $122.68 on Friday. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.39 and a current ratio of 2.42. Teleflex Incorporated has a 1-year low of $118.70 and a 1-year high of $249.91. The company's fifty day moving average is $127.86 and its two-hundred day moving average is $154.81. The stock has a market capitalization of $5.42 billion, a price-to-earnings ratio of 24.39, a price-to-earnings-growth ratio of 1.73 and a beta of 1.10.

Teleflex (NYSE:TFX - Get Free Report) last released its quarterly earnings data on Thursday, May 1st. The medical technology company reported $2.91 earnings per share for the quarter, topping analysts' consensus estimates of $2.88 by $0.03. The business had revenue of $700.67 million for the quarter, compared to analysts' expectations of $699.37 million. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. The company's revenue for the quarter was down 5.0% compared to the same quarter last year. During the same quarter last year, the company earned $3.21 EPS. Equities analysts anticipate that Teleflex Incorporated will post 13.98 EPS for the current year.

Teleflex Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Monday, June 16th. Investors of record on Tuesday, May 20th will be given a $0.34 dividend. The ex-dividend date of this dividend is Tuesday, May 20th. This represents a $1.36 dividend on an annualized basis and a yield of 1.11%. Teleflex's dividend payout ratio is presently 42.90%.

Wall Street Analysts Forecast Growth

TFX has been the subject of a number of analyst reports. Mizuho set a $155.00 price objective on shares of Teleflex in a research report on Wednesday, April 16th. Needham & Company LLC reiterated a "hold" rating on shares of Teleflex in a research note on Wednesday, March 12th. Raymond James downgraded shares of Teleflex from an "outperform" rating to a "market perform" rating in a research note on Friday, February 28th. Wells Fargo & Company decreased their target price on shares of Teleflex from $146.00 to $137.00 and set an "equal weight" rating for the company in a research note on Friday, May 2nd. Finally, Bank of America cut shares of Teleflex from a "neutral" rating to an "underperform" rating and cut their price target for the company from $235.00 to $140.00 in a report on Tuesday, March 4th. One equities research analyst has rated the stock with a sell rating, nine have given a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of "Hold" and an average target price of $164.63.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.